| |
News from Medical
News Today Feb. 26, 2007
Treatment For
Advanced ALD Patients Uncovered By U Of MN Doctors
Continuing with more than a decade of research, doctors at the
University of Minnesota have discovered a treatment to help patients
with advanced cases of
adrenoleukodystrophy (ALD), a rare disorder affecting the
nerves. The results are published in the late February issue of Bone
Marrow Transplantation.
ALD is a progressive degenerative myelin disorder that affects young
boys. Myelin is the "insulation" around the nerves and with ALD it
breaks down over time and causes loss of hearing, sight, mobility,
and general nerve function. Left untreated, patients with ALD will
die, usually within three to five years of diagnosis. There is no
cure, but the progression of the disease can be halted with a bone
marrow transplant. However, in very advanced cases, transplant is
not recommended because patients die within a year despite
transplantation.
Doctors began giving patients with very advanced ALD who would not
otherwise be eligible for transplant, a medication called N-acetyl
L-cysteine (NAC), an anti-inflammatory drug used to help liver cells
recover from Tylenol® (acetaminophen) overdose. In these advanced
cases, the combination of NAC and transplant halted the disease
progression and allowed these patients to survive transplant. Post
transplant brain scans showed a decrease in inflammation and
preservation of myelin after administering NAC.
"We believe that NAC can also help patients with less advanced cases
of ALD, and possibly other diseases of inflammation of the myelin,"
said Lawrence Charnas, M.D., Ph.D., senior author and pediatric
neurologist at the University of Minnesota Children's Hospital. "This
is a major step forward in treating a devastating disease."
###
The University of Minnesota Children's Hospital is among the world's
leaders in treating children with ALD and other metabolic storage
diseases. This research was funded by the Children's Cancer Research
Fund and the University of Minnesota Department of Pediatrics.
Contact: Sara Buss
University of Minnesota
http://www.medicalnewstoday.com/medicalnews.php?newsid=63551&nfid=rssfeeds
<----back |
|